Holen Sie sich die Stockscreener-App
2.47
6.93%
0.16
Finanzdaten der Sangamo Therapeutics Inc-Aktie (SGMO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
76.44%
0.481
|
2.042 | 9.398 | 6.835 | 157.96 |
Operating Expenses
|
18.87%
52.01
|
64.10 | 115.81 | 130.41 | 139.92 |
| Benefits Costs and Expenses |
20.98%
49.47
|
62.61 | 112.29 | 127.61 | 136.63 |
| Costs And Expenses |
20.98%
49.47
|
62.61 | 112.29 | 127.61 | 136.63 |
| Operating Income/Loss |
16.97%
-51.53
|
-62.06 | -106.41 | -123.57 | 18.03 |
| Income/Loss From Continuing Operations Before Tax |
19.11%
-48.99
|
-60.57 | -102.89 | -120.77 | 21.33 |
| Income Tax Expense/Benefit |
136.03%
0.098
|
-0.272 | 1.27 | -6.264 | 0.194 |
| Income/Loss From Continuing Operations After Tax |
18.59%
-49.09
|
-60.30 | -104.16 | -114.51 | 21.13 |
|
Net Income/Loss
|
18.59%
-49.09
|
-60.30 | -104.16 | -114.51 | 21.13 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
16,770%
180.34
|
1.069 | 177.17 | 174.32 | 168.53 |
| Diluted Average Shares |
16,770%
180.34
|
1.069 | 177.17 | 174.32 | 169.18 |
| Basic Earnings Per Share |
20.59%
-0.27
|
-0.34 | -0.59 | -0.66 | 0.13 |
| Diluted Earnings Per Share |
20.59%
-0.27
|
-0.34 | -0.59 | -0.66 | 0.12 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):